Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829204 · ClinicalTrials.gov registry record
Prospective Data Bank Creation to Study Vaginal Conditions
A clinical trial of Bacterial Vaginosis and Vulvodynia, sponsored by Texas Tech University Health Sciences Center.
- Recruiting
- Registry status
- 550
- Enrollment target
- 1
- Study location
NCT01829204 is a study of Bacterial Vaginosis and Vulvodynia that is actively recruiting participants, run by Texas Tech University Health Sciences Center. The registered enrollment target is 550 participants, above the 302-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (82% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01829204, a study of Bacterial Vaginosis and Vulvodynia, is actively recruiting participants, sponsored by Texas Tech University Health Sciences Center.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.
Conditions Studied
Study Locations (1)
Texas
- TTUHSC Permian Basin - Midland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2013-04 |
| Est. Completion | 2027-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01829204
The ClinicalTrials.gov registry entry for NCT01829204 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 302-participant average among 15 other Bacterial Vaginosis trials with a reported enrollment target (82% higher). The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Bacterial Vaginosis appearing as the primary indexed condition, and to 0 interventions.
NCT01829204 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01829204 about?
NCT01829204 is a clinical study titled "Prospective Data Bank Creation to Study Vaginal Conditions". The purpose of this study is to identify and elucidate the pattern and perhaps role of atypical proteins, cytokines and vaginal microbial flora in the pathogenic mechanisms involved in the development of vulvodynia, recurrent fungal and bacterial vaginosis and preterm labor.
What is the current status of trial NCT01829204?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2013-04. Estimated completion is 2027-12.
What conditions does trial NCT01829204 study?
This clinical trial studies the following conditions: Bacterial Vaginosis, Vulvodynia, Preterm Labor, Mycoses.
Who is sponsoring clinical trial NCT01829204?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01829204 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacterial Vaginosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Protocol CERN Feasibility Study
RECRUITING · NA
-
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
RECRUITING · Early Phase 1
-
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
ACTIVE NOT RECRUITING · Phase 2
-
Treatment of Bacterial Vaginosis (BV) With Tinidazole
COMPLETED · Phase 4
-
Performance Study of the Cobas® BV/CV Test on Samples From Participants With and Without Symptoms of Bacterial Vaginosis and Candida Vaginitis
COMPLETED
-
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.